Trends in substance abuse and infectious disease over 20 Years in a large methadone maintenance treatment (MMT) clinic in Israel

Substance Abuse

Volumn 35, Issue 3, 2014, Pages 226-229

  Peles, Einat ^a,b   Schreiber, Shaul ^a,b   Adelson, Miriam ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hepatitis C; HIV; methadone maintenance treatment; outcome; substance abuse trends

Indexed keywords

METHADONE;

ADULT; DRUG DEPENDENCE TREATMENT; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; ISRAEL; MALE; OPIATE SUBSTITUTION TREATMENT; PATIENT ATTITUDE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; TRENDS;

ADULT; FEMALE; HEPATITIS C; HIV SEROPREVALENCE; HUMANS; ISRAEL; MALE; METHADONE; OPIATE SUBSTITUTION TREATMENT; PATIENT ACCEPTANCE OF HEALTH CARE; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84922284632     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2014.899944     Document Type: Article

References (21)

1. Adelson MO, Hayward R, Bodner G, Bleich A, Gelkopf M, Kreek MJ. Replication of an effective opiate addiction pharmacotherapeutic treatment model: minimal need for modification in a different country. J Maint Addict. 2000;1:5-13.
2. Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006;82:211-217.
3. Peles E, Schreiber S, Sason A, Adelson M. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program. J Addict Med. 2011;5:92-98.
4. Peles E, Schreiber S, Sason A, Adelson M. Long waiting period to enter methadone maintenance treatment: relation to patient characteristics and outcome. Eur Addict Res. 2012;18:149-152.
5. Hawks RL Analytical methodology. NIDA Res Monogr. 1986;73:30-42.
6. Effective Medical Treatment of Opiate Addiction. NIH Consensus Statement. 1997, November 17-19;15(6):1-38. Available at: http:// consensus.nih.gov/1997/ 1998TreatOpiateAddiction108html.htm
7. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade. Arch Intern Med. 1966;118:304-309.
8. Kreek MJ. Plasma and urine levels of methadone. N Y State J Med. 1973;73:2773-2777.
9. US Federal Register 21 CRF Part 291 and 42 CRF Part 8 (January 17, 2001). Opioid Drug in Maintenance and Detoxification Treatment of Opiate Addiction; Final Rule.
10. Bar-Hamburger R, Shufman E. Changes in psychoactive drug use in Israel from 1990 until 2001. Isr J Psychiatry Relat Sci. 2002; 39:79-82.
11. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP. The effects of psychosocial services in substance abuse treatment. JAMA. 1993;269:1953-1959.
12. Kreek MJ, LaForge KS, Butelman E. Pharmacotherapy of addictions. Nat Rev Drug Discov. 2002;1:710-726.
13. Unterwald EM, Horne-King J, Kreek MJ. Chronic cocaine alters brain mu opioid receptors. Brain Res. 1992;584:314-318.
14. Unterwald EM, Rubenfeld JM, Kreek MJ. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport. 1994;5:1613-1616.
15. Unterwald EM, Kreek MJ, Cuntapay M. The frequency of cocaine administration impacts cocaine-induced receptor alterations. Brain Res. 2001;900:103-109.
16. Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25:43-50.
17. Ministry of Health. HIV/AIDS in Israel: Periodic Epidemiological Report 1981-2011 [Hebrew]. Available at: http://www.health. gov.il/PublicationsFiles/ AIDS-PeriodicReport2012.pdf.pdf(page4). Published 2012. Accessed June, 2014.
18. Israel Central Bureau of Statistics. Persons diagnosed with HIV and AIDS,by exposure category and sex. Available at: http://www.cbs.gov. il/shnaton64/st06-16.pdf. Published2014.Accessed 2014.
19. Zuckerman E. Liver Unit, Carmel Medical Center, Haifa, Israel. Hepatitis C in Israel. Conversation with H. A. Razavi, Center for Disease Analysis, Kromite, Louisville, CO, USA, 2 October 2010.
20. Cornberg M, Razavi HA, Alberti A, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011;2:30-60.
21. Peles E, Rados V, Adelson M. Characterization of former heroin addict patients with Hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in Israel. Subst Use Misuse. 2007;42:1477-1484.